from the approval date; (5) having the study or research results that show the possibility of providing innovative financial services; (6) having no record of violating or failing to comply with the
/2563 2.1543 3.4271 5.5814 246003662005-1 HUMAN WASATCH ADVISORS, INC. จำหน่าย หุ้น 5.8926 0.9036 4.989 13/02/2563 5.8926 0.9036 4.989 246002552002-1 HUMAN CAPITAL RESEARCH AND MANAGEMENT COMPANY
/2563 2.1543 3.4271 5.5814 246003662005-1 HUMAN WASATCH ADVISORS, INC. จำหน่าย หุ้น 5.8926 0.9036 4.989 13/02/2563 5.8926 0.9036 4.989 246002552002-1 HUMAN CAPITAL RESEARCH AND MANAGEMENT COMPANY
professionals, especially securities analysts, to attain better knowledge and deeper learning of ESG data analysis and integrate this information into their research reports. In addition, the emphasis on ESG in
expenses 30 28 2 7% 8.0% 7.3% Finance costs 11 13 (2) -18% Share of loss from associate 0 - Income tax expense (1) 1 (3) Profit for the quarter 17 (7) 24 4.6% (1.8%) Consolidated financial information (Unit
majority of the Company’s expenses came from employee benefits expenses, fee and service expenses, and finance costs, as follows: KGI Securities (Thailand) Public Company Limited 173 Asia Centre Building
(59.64) -13.5% Cost 348.48 384.03 Gross profit 34.96 59.05 (24.09) -40.8% Gross profit margin 9.1% 13.3% Other income 1.04 0.14 0.90 Selling & Admin expenses 28.14 33.31 (5.18) -15.5% 7.3% 7.5% Finance
Laboratory and Research Center (“AMARC”). Costs and Expenses The Company reported the consolidated costs and expenses for Q1/2019 of Baht 345.54 million, nearby of Q1/2018 of Baht 345.61 million decreased by
booked in year 2018 for chronic diseases were then subtracted accordingly. However, the service revenues (mainly received from Asia Medical and Agricultural Laboratory and Research Center Co., Ltd “AMARC
to the hospital. In regard to the subsidiary, Asia Medical & Agricultural Laboratory and Research Center (“AMARC”), its service revenues grew by 12.60% as it provides laboratory testing and analyzing